InvestorsHub Logo
Followers 5
Posts 154
Boards Moderated 0
Alias Born 01/07/2021

Re: None

Thursday, 02/04/2021 1:30:23 PM

Thursday, February 04, 2021 1:30:23 PM

Post# of 111071
"The data disclosed today support the possibility that ImmCelz® truly is a form of 'regenerative immunotherapy,' " said Dr. Amit Patel, co-inventor of the patent.  "To my knowledge this is the first cellular therapy in which immune cells, particularly T cells, are programmed by coculture with umbilical cord stem cells to generate a product that actually induces production of regenerative cytokines in vivo."
Our holy grail! Just my observation! :)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News